5 terminated. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
| Phase 1 | 3 | Terminated 3 |
Follow ECG: new trials by email Literature Review of ECG trials Research Report on ECG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma Olaparib, ECG, CT CAP - Pancreatic Acinar Cell Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 5 | 2023-12-14 | 2026-08-14 |
| Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes KPT-8602, Inqovi, Bone marrow aspirate - Myelodysplastic Syndromes | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 3 | 2023-11-14 | 2025-12-02 |
| BMS-986253 in Myelodysplastic Syndromes Deoxyribonucleic acid (DNA) methyltransferase inhibitors (DNMTi) Decitabine, Deoxyribonucleic acid (DNA) methyltransferase inhibitors (DNMTi) Cedazuridine, BMS-986253 - Myelodysplastic Syndromes | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2022-11-29 | 2025-09-30 |
| Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer EP0057, olaparib, CT scan - Urothelial Carcinoma, Urothelial Cancer | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 45 | 2016-05-09 | 2026-08-13 |
| ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure ZP120, I.v. catherization, 6-minutes walk performance - Heart Failure, Congestive | Phase 2 | Terminated | Zealand Pharma | 130 | 2006-01-01 | 2007-02-28 |
Myelodysplastic Syndromes (2) · Carcinoma, Transitional Cell (1) · Cytopenia (1) · Heart Failure (1) · Leukemia, Myeloid, Acute (1) · Lung Neoplasms (1) · Prostatic Neoplasms (1) · Small Cell Lung Carcinoma (1)
National Cancer Institute (NCI) (4) · Zealand Pharma (1)
United States (5)
Najla El Jurdi, M.D. (2) · Anish Thomas, M.D. (1) · Chen Zhao, M.D. (1)